,,ii #aagth ,,congress #ast ,session ,s4 #cdja ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,december #ae1 #bjba,mr4 ,cotton 7for himself and ,mr4 ,braun7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to require the ,secretary of ,health and ,human ,services to maintain a list of the country of origin of all drugs marketed in the ,united ,states1 to ban the use of ,federal funds for the purchase of drugs manufactured in the ,people's ,republic of ,china1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,anyone ,but ,china ,safe ,drug ,act or the ,,abc ,safe ,drug ,act4 #b4 ,country of origin of drugs 7a7 ,in general ,subchapter ,a of chapter ,v of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cea et seq47 is amended by adding at the end the following3 #ebd;,b4 ,registry of drugs produced outside the ,,us 7a7 ,in general ,the ,secretary shall compile and maintain a list of all drugs approved under subsection 7c7 or 7j7 of section #eje of this ,act or licensed under subsection 7a7 or 7k7 of section #cea of the ,public ,health ,service ,act1 and any active ingredients in such drugs1 that-- 7#a7 are manufactured outside of the ,united ,states2 and 7#b7 are determined by the ,secretary to be critical to the health and safety of consumers in the ,united ,states4 7b7 ,additional list ,in conjunction with the list described in subsection 7a71 the ,secretary shall compile and maintain a list of drugs included on such list that are exclusively produced in1 or use active or inactive ingredients produced in1 the ,people's ,republic of ,china4 7c7 ,requirement ,the list described in subsection 7a7 shall1 with respect to each drug included on the list1 provide information about the supply chain of the drug1 including each step in the supply chain that occurs prior to importation of the drug into the ,united ,states4 4 7b7 ,federal health program purchase of drugs 7#a7 ,in general ,notwithstanding any other provision of law1 with respect to the purchase of a drug by the ,department of ,health and ,human ,services1 the ,department of ,veterans ,affairs1 the ,department of ,defense1 or any other ,federal health care program 7as defined in section #aabh;,b7f7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acbj;a-#g;b7b7771 the following shall apply3 7,a7 ,beginning on ,january #a1 #bjbd1 such agency or program may purchase only drugs for which #fj percent or more of the active pharmaceutical ingredients are manufactured in countries described in paragraph 7#b74 7,b7 ,beginning on ,january #a1 #bjbf1 such agency or program may purchase only drugs for which #ajj percent of the active pharmaceutical ingredients are manufactured in countries described in paragraph 7#b74 7#b7 ,countries described ,the countries described in this paragraph are countries-- 7,a7 other than ,people's ,republic of ,china2 and 7,b7 that meet the health and safety standards of the ,food and ,drug ,administration4 7#c7 ,waivers ,the ,secretary of ,health and ,human ,services may issue waivers of the requirements under paragraph 7#a7 for any agency or program that is unable to meet such requirements and demonstrates a need for the waiver4 ,no waiver may be issued under this paragraph for drugs that are purchased on or after ,january #a1 #bjbg4 7c7 ,labeling requirement ,section #ejb of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #ceb7 is amended by adding at the end the following3 7gg7 ,if it is a drug and its labeling does not specify the country of origin of each active ingredient contained in the drug4 4